NCT00333736View on ClinicalTrials.gov

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

PHASE2CompletedINTERVENTIONAL

Enrollment

337

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2008

Conditions

Human Immunodeficiency Virus

Interventions

DEVICE

Biojector

All patients received biojector to use with BID enfuvirtide doses

Trial Locations (1)

M5B 1L6

Maple Leaf Medical Clinic, Toronto

All Listed Sponsors

collaborator

Roche Pharma AG

INDUSTRY

lead

Canadian Immunodeficiency Research Collaborative

OTHER

NCT00333736 - Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration | Biotech Hunter | Biotech Hunter